Skip to content

Clinical Study on the Role of ET-1 and Its Receptors in Angiogenesis of Ovarian Endometriosis Cysts

Clinical Study on the Role of ET-1 and Its Receptors in Angiogenesis of Ovarian Endometriosis Cysts

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600126847
Enrollment
Unknown
Registered
2026-06-17
Start date
2026-06-17
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometriosis

Interventions

Observation group:None
Control group:None

Sponsors

Soochow University Affiliated Second Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Observation Group: 1. Imaging and blood tests indicated ovarian endometriosis cysts and required surgical treatment; 2. Previously healthy, without history of chronic diseases or infectious diseases; 3. No history of malignant tumors; 4. Regular menstrual cycle and normal menstrual volume; 5. No previous drug treatment for half a year; 6. Informed and agreed to participate in the experiment. Control Group: 1. Imaging and blood tests indicated ovarian serous cysts and required surgical treatment; 2. Previously healthy, without history of chronic diseases or infectious diseases; 3. No history of malignant tumors; 4. Regular menstrual cycle and normal menstrual volume; 5. No previous drug treatment for half a year; 6. Informed and agreed to participate in the experiment.

Exclusion criteria

Exclusion criteria: 1. Exclude the possibility of uterine endometrial malignancy; 2. Exclude acute pelvic inflammation; 3. Patients with severe coagulation disorders, liver and kidney dysfunction, or other conditions that make them intolerant to surgery; 4. Patients with precancerous lesions or malignant tumors; 5. Those who have used hormone drugs within the past six months.

Design outcomes

Primary

MeasureTime frame
Endothelin-1;Vascular Endothelial Growth Factor;Hypoxia-Inducible Factor-1a;CD34;

Countries

China

Contacts

Public ContactRen Qiongzhen

Soochow University Affiliated Second Hospital

renqiongzhen@163.com+86 512 6778 4769

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 29, 2026